- Pharmaceuticals form 13 per cent of Singapore’s exports to the US, amount to US$3.1 billion (RM13 billion)
- Many pharma firms in Singapore may qualify for a tariff exemption, says deputy PM
- Trade talks ongoing for pharmaceutical and semiconductor sectors
SINGAPORE, Sept 27 — Pharmaceutical companies in Singapore are seeking clarification on whether they would qualify for an exemption from steep tariffs imposed by the United States on their goods, Singapore’s Deputy Prime Minister Gan Kim Yong said today.
Singapore exports about S$4 billion (RM13 billion) of pharmaceutical products to the US and most of these exports are branded drugs, Gan, who is also trade minister, told reporters.
US President Donald Trump announced on Thursday 100 per cent duties on imports of branded drugs that would apply to firms unless they build a manufacturing presence in the US
This is a concern for Singapore as pharmaceuticals form around 13 per cent of all Singapore exports to the US, said Gan.
He said that many of the pharmaceutical firms in Singapore have existing plans to expand or build their business footprint in the US, which may qualify them for a tariff exemption.
Gan, who met US Commerce Secretary Howard Lutnick in August, said trade talks with the US are ongoing, with officials on both sides working on details of possible deals for the pharmaceutical and semiconductor sectors.
“Ultimately, we hope to be able to have an arrangement with the US to allow us to continue to be competitive in the US market, to allow our pharmaceutical companies to be able to continue to export to the US market. As to whether the tariff rate will be 15 per cent or any other tariff is something that is part and parcel of the negotiation, but we do look forward to having some preferential treatment versus the current top-line tariff the US has imposed,” said Gan.
Singapore’s exports to the US are subject to a 10 per cent baseline tariff despite a free trade agreement in place with the island nation since 2004. Broader sectoral tariffs could hurt demand for Singaporean products, including semiconductors, consumer electronics and pharmaceutical goods, which the central bank in July said account for about 40 per cent of exports to the United States.
The effective US tariff rate on Singapore’s exports rose to 7.8 per cent in July from 6.8 per cent in April on the back of steel and aluminium tariff hikes. — Reuters
